August 25, 2020
Fitbit announced today three new wearables – the Fitbit Sense, Fitbit Versa 3 and Fitbit Inspire 2 – to its product pipeline.
The Fitbit Sense marks the company’s first “advanced health” smartwatch, including an electrodermal activity (EDA) sensor, an electrocardiogram app, a heart rate tracker and an on-wrist skin temperature sensor with more than six days of battery life. It costs $329 and...
August 6, 2020
Alongside yesterday's reveal of the Galaxy Watch3, Samsung announced that it has received regulatory clearance from the FDA for its ECG monitoring app.
But while the watch – which also has built-in sensors enabling blood pressure and blood oxygen saturation – is slated for release on Aug. 6, the company did not say specifically when the new Samsung Health Monitor app that enables these features...
July 9, 2020
AliveCor released today KardiaCare, a digital subscription service for managing heart health at home.
The service offers a suite of features that helps users interpret their heart data, monitor risk factors, identify symptom triggers and measure the impact of lifestyle changes. It will expand upon the features already provided with the company’s other ECG products, KardiaMobile and KardiaMobile...
May 26, 2020
Samsung is the latest wearable company to enter the ECG monitoring space, following an announcement on Sunday that the function on its Health Monitoring app got the greenlight from South Korea’s Ministry of Food and Drug Safety.
This means that Galaxy Watch Active2 users in South Korea will be able to use the tool to detect any heart rhythm irregularities, which could be linked to AFib.
March 18, 2020
Femtech company Bloomer raised $3 million in seed-round funding for its bra-like ECG tech. The latest round was led by Material Impact with participation from One Brave Idea and several angel investors.
WHAT THEY DO
The MIT-spinoff is putting electrocardiogram sensors and machine learning algorithms into the fabric of a bra. The tech is able to track a woman’s health data over time. In addition...
January 22, 2020
Editor's note: This story has been updated with information from Verily's announcement of the clearance.
Verily, the life sciences research subsidiary of Alphabet, has received FDA 510(k) clearance for an augmented version of its prescription Study Watch wearable that includes some form of arrhythmia monitoring.
The Study Watch With Irregular Pulse Monitor is classified by the FDA as a “...
January 6, 2020
French digital health company Withings has unveiled its latest smartwatch dubbed ScanWatch, which will include an ECG and Sp02 sensor.
The watch comes with a PPG sensor, which will continuously monitor the user's heart rate and alert users if there is an irregularity. If any issues are detected, the watch will prompt the user to take an ECG reading. Watch wearers can read the ECG on the screen...
November 22, 2019
There are few clinical areas more in need of innovation than heart disease. It’s the leading killer among men and women in the US, accounting for one in every four deaths by the CDC’s numbers, and yet it’s also a body of health conditions that could be substantially mitigated through a number of lifestyle and behavior changes.
So of course it’s little surprise that cardiovascular health and care...
October 31, 2019
Digital ECG maker AliveCor is teaming up with Chinese wearable company Huami Corporation on a new effort to combine the pair’s technology into medical-grade wearables.
The end goal is to have an ECG-enabled wearable with various heart features on the market by 2020.
"AliveCor's agreement with Huami achieves our corporate goal of delivering AliveCor's AI-driven subscription services and...
October 17, 2019
Fitbit will be working with the cardiovascular-focused Bristol-Myers Squibb-Pfizer Alliance to develop “educational content and guidance” that will help device owners recognize if they are at risk of atrial fibrillation, as well as to seek appropriate support and diagnosis of the condition.
A spokesperson for the companies noted that although the specifics of these programs are still in...